GLI AUGURI DI AMD Share Post navigation Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: a retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular diseaseOGGI ALLE ORE 15.00 – WEBINAR “I NUOVI ANNALI AMD”
